Moreover, the capability of mono-derived DCs, generated in the presence of IFN-α (IFN-DCs), to prime CD8+ T cells against human tumor antigens is dependent on NK cells; NK cell removal indeed leads to generation of IFN-DCs with no priming activity of tumor Ag-specific T cells (68). The gene discussed is IFNA17; the disease is neoplasm.